Tiziana Life Sciences News

EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert

Trading expert and author Anne-Marie Baiynd joined Benzinga's YouTube on Tuesday to discuss current option trade ideas. Baiynd highlighted three separate potential Tesla Inc (NASDAQ:TLSA) option trade

BenzingaMay 15 20:11

Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab

NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via nov

GlobeNewswireMay 13 19:00

Tiziana Eyes Orphan Drug Designation for Multiple Sclerosis Treatment | NASDAQ:TLSA

Proactive InvestorsMay 13 16:22

Tiziana Life Sciences | 20-F: Registration statement / Annual report / Transition report

Futu NewsMay 11 05:06 · Announcements

Tiziana Life Sciences' Intranasal Therapy Shows Promise

TipRanksApr 25 22:57

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via n

GlobeNewswireApr 25 22:00

Tiziana Life Sciences Unveils Positive Neuroimaging Data for Foralumab in MS Patients | NASDAQ:TLSA

Proactive InvestorsApr 25 18:56

Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results.Tesla posted weaker-than-expected earnings and sales results for its first quarter on Tue

BenzingaApr 24 20:09

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million. ABVC BioPharma (NAS

BenzingaApr 24 04:31

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks were advancing Tuesday afternoon, with the NYSE Health Care Index gaining 1.4% and the Health Care Select Sector SPDR Fund (XLV) up 1.3%. The iShares Biotechnology ETF (IBB) rose 1.

MT NewswiresApr 24 01:51

Tiziana Spikes as FDA Clears Additional Patients for Expanded Access Program

Seeking AlphaApr 23 20:05

Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to Be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program

NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug

GlobeNewswireApr 23 19:00

Tiziana Life Sciences Wins FDA Approval to Add Patients to MS Program | NASDAQ:TLSA

Proactive InvestorsApr 23 16:40

Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in Its Expanded Access Program

70% of Patients in the Expanded Access Program (EAP) Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Follow-upAll Patients Have Either Stabilized or Improved on Nasal Foralumab Treatment

GlobeNewswireApr 22 19:00

Tiziana Life Sciences Reports Additional Positive Results From Multiple Sclerosis Program | NASDAQ:TLSA

Proactive InvestorsApr 22 16:46

12 Health Care Stocks Moving In Friday's After-Market Session

GainersMobile-health Network (NASDAQ:MNDR) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. Galera Therapeutics (NASDAQ:GRTX) stock in

BenzingaApr 20 04:31

Tiziana Life Sciences' MS Treatment Shows Potential

TipRanksApr 19 19:31

Tiziana Life Sciences Announces Study Results From Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients With PIRA Highlighted in Neurology Today

- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in a platform session at the

GlobeNewswireApr 19 19:00

Tiziana Life Sciences' Foralumab Study Highlighted in Neurology Today | NASDAQ:TLSA

Proactive InvestorsApr 19 17:06

Tiziana Life Sciences Shares Are Trading Higher. The Company Announced a New Quantitative PET Imaging Data on Foralumab.

Tiziana Life Sciences Shares Are Trading Higher. The Company Announced a New Quantitative PET Imaging Data on Foralumab.

BenzingaApr 19 03:20